Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADRB2 | P07550 | 2/20 | 0.57 |
| ▸ | ADRB3 | P13945 | 11/20 | 0.55 |
| ▸ | ADRB1 | P08588 | 2/20 | 0.54 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7056967 | 0.89 | ADRB3 (0.50) | ADRB2ADRB3ADRB1KDM4E | |
| SCHEMBL7058826 | 0.83 | ADRB3 (0.45) | ADRB2ADRB3ADRB1 | |
| SCHEMBL7058823 | 0.83 | ADRB3 (0.45) | ADRB2ADRB3ADRB1 | |
| SCHEMBL7058117 | 0.82 | ADRB3 (0.44) | ADRB2ADRB3ADRB1 | |
| SCHEMBL7058116 | 0.82 | ADRB3 (0.44) | ADRB2ADRB3ADRB1 | |
| SCHEMBL5848784 | 0.81 | ADRB2 (0.54) | ADRB2ADRB3KDM4E | |
| SCHEMBL5848811 | 0.81 | ADRB2 (0.54) | ADRB2KDM4E | |
| Hydrochloric Acid SCHEMBL29375517 | 0.81 | ADRB2 (0.54) | ADRB2ADRB3ADRB1KDM4E | |
| SCHEMBL5848437 | 0.80 | ADRB2 (0.55) | ADRB2ADRB3ADRB1KDM4E | |
| SCHEMBL9006647 | 0.80 | ADRB3 (0.70) | ADRB3ADRB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7112605-B2 | Sulfonyl-containing 3,4-diaryl-3-pyrrolin-2-ones, preparation method, and medical use thereof | Research Institute of Materia Medica Chinese Acadamy of Medical Sciences (CN) | 2006-09-26 | — | — | US | disclosed |
| US-20040029951-A1 | Sulfonyl-containing 3,4-diaryl-3-pyrrolin-2-ones, preparation method, and medical use thereof | RESEARCH INSTITUTE OF MATERIAL MEDICA, CHINESE ACADEMY OF MEDICAL SCIENCES; | 2004-02-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040029951-A1 | Sulfonyl-containing 3,4-diaryl-3-pyrrolin-2-ones, preparation method, and medical use thereof | PTGS1, PTGS2, PTGER1 | ADRB2 768/4885ADRB3 587/4885ADRB1 881/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.